OPTEGEN technology is a next generation in vitro test that provides clinicians with a front-line solution leading to early diagnosis of allergy conditions.

OPTIGEN results are
Accurate, reliablere, producible, and correlate well with skin testing and single allergen systems.

The unique value of OPTIGEN is its minimal serum requirement, making it an ideal tool for early diagnosis.

Clinicians can receive between 20 and 36 specific IgE results from a single serum sample.

It eliminates inventory of individual allergens and decreases waste. With lower serum requirements, smaller volumes of serum controls are necessary, further reducing cost.

OPTIGEN, is a three-step process with same day results, requires minimal training. It provides plenty of "walk-away" time, allowing staff to perform other duties. The panel format also decreases "handling" for technicians.